| E | concepts in biomedical areas b-out d-out qh |
| SN | Biology and psychology overlap; thus some descriptors needed to index biomedical topics are found in *+FA psychology* qh ah. | |
| NT | +AK4.2e biological AODC qh ah | |
| +GA10.2.2 biological disease cause qh ah | ||
| +PDe epidemiology qh ah |
| EAe | general life processes d-out qh |
| HN | ETOH descriptor 2000. | |
| SN | Refers to normal life processes of biological organisms or body parts. For cellular life processes, see *+EG cell function* qh ah and *+XA cell and cell structure* qh ah. | |
| ST | physiology | |
| NT | +EBe metabolism qh ah | |
| +EC biological transport and storage qh ah | ||
| +EDe growth and development qh ah | ||
| +EGe cell function qh ah | ||
| +EH body system or organ function qh ah | ||
| RT | +W living organisms qh ah | |
| +Xe body part qh ah |
| EA2e | electrical life processes qh |
| HN | Introduced 2000. | |
| ST | electrophysiology | |
| NT | +EG8e cell electrophysiology qh ah |
| EA4e | biochemical mechanism qh |
| SN | The ways in which biological and psychological functions are affected by chemical reactions. Combine with a descriptor from *+CL chemical reaction* qh ah and a descriptor for the biological or psychological function as appropriate. | |
| NT | +EBe metabolism qh ah | |
| +EE12.4.4e drug binding qh ah | ||
| RT | +AJ4e biological AOD use disorder theory qh ah | |
| CK2.4e structure activity relationship qh ah | ||
| +CL10e biochemical reaction property qh ah | ||
| +EEe pharmacology and toxicology qh ah | ||
| +EE14.4 drug effect qh ah | ||
| +FAe psychology qh ah | ||
| +FPe emotion qh ah | ||
| +FQe psychological stress qh ah | ||
| +FRe attitude and behavior qh ah |
| EA6 | body chemistry qh |
| HN | Introduced 1995. | |
| SN | The chemical composition of and distribution of chemical substances within the body and/or its parts. | |
| RT | +EA10.4e body composition qh ah | |
| +HF18e blood chemistry qh ah |
| EA8e | biological regulation qh |
| SN | For the regulation of specific systems or processes, use this section and the body system, organ function, or process involved. For example, acid-base balance regulation or electrolyte balance regulation may be indexed as *+EA8 biological regulation* qh ah and *+EB2 homeostasis* qh ah. Regulation of ethanol metabolism may be indexed as *+EB10.12 ethanol metabolism* qh ah and *+EA8 biological regulation* qh ah. | |
| NT | +EA24.8.8 nutrient intake regulation qh ah | |
| RT | +EB2e homeostasis qh ah | |
| +EE14.4 drug effect qh ah | ||
| +ET4e immune function qh ah | ||
| +EUe endocrine function qh ah | ||
| +EWe nervous system function qh ah | ||
| +EW12.6.4.6 diencephalic brain model qh ah | ||
| +EX8.6e gene regulation qh ah | ||
| +FD18.8e self-regulation qh ah | ||
| +GR20.12.2e edema qh ah |
| EA8.2 | . regulatory loop qh |
| SN | For example, a biosynthetic pathway is made up of a series of enzymes that take a molecule and convert it into another molecule through a sequence of catalyzed reactions. Feedback regulation is the mechanism by which biosynthetic and catabolic pathways regulate themselves. These pathways have evolved self-regulation such that, if too much of the end product or a byproduct is around it, it acts as an inhibitor of an earlier reaction. | |
| ST | regulatory circuit | |
| RT | +EU2.4e hypothalamic-pituitary-adrenal axis qh ah |
| EA8.2.2e | . . biological feedback qh |
| EA8.2.2.2 | . . . positive biological feedback qh |
| EA8.2.2.4 | . . . negative biological feedback qh |
| EA8.2.2.4.2 | . . . . feedback inhibition qh |
| SN | The inhibition of enzyme activity in which the products of a reaction or series of reactions acts upon the enzyme(s) responsible for the generation of that product.
Thus, the abundance of a substance slows the rate of production of that substance. If, similarly, low concentration of a substance increases the rate of production then there should exist a stable concentration (or range of concentrations) of that substance that is maintained over time. | |
| BT | +CL10.2 enzyme specificity qh ah |
| EA8.4e | . biological activation qh |
| RT | +EA22.4 biological rest qh ah |
| EA8.4.2 | . . biological arousal qh |
| NT | ES8 sexual arousal qh ah | |
| RT | +FF2e awareness qh ah | |
| GZ30.4.8 inhibited sexual arousal qh ah |
| EA8.6 | . biological stimulation qh |
| RT | +CHe sensory stimuli qh ah | |
| +EV2e sensation qh ah | ||
| FG4 perceptual stimulation qh ah |
| EA8.8e | . biological inhibition qh |
| RT | FR20.2e inhibition qh ah |
| EA8.8.2 | . . biological blockade qh |
| EA8.10 | . biological termination qh |
| ST | biological stopping | |
| biological suppression | ||
| interruption of biological process |
| EA8.12e | . biological modulation qh |
| HN | ETOH descriptor 2000. | |
| SN | The functional and morphologic adaptations of cells to changes in the environment. This includes the modification of an effect or reaction. | |
| NT | ET4.4.2e immunomodulation qh ah |
| EA8.14 | . biological integration qh |
| RT | +EA22.6.2 restoration of structure qh ah | |
| +EUe endocrine function qh ah | ||
| +EWe nervous system function qh ah |
| EA8.16e | . thermoregulation qh |
| ST | regulation of body temperature | |
| RT | EA12e body temperature qh ah | |
| +EKe skin function qh ah | ||
| +EK2e sweating qh ah | ||
| +EW12.6.4.6 diencephalic brain model qh ah | ||
| GF2.16 fever qh ah | ||
| GF2.18 chill qh ah | ||
| GH8.6.2e hyperthermia qh ah | ||
| GH8.6.4e hypothermia qh ah |
| EA8.16.2 | . . thermogenesis qh |
| EA8.16.2.2 | . . . shivering qh |
| EA8.18 | . bioperiodicity qh |
| ST | biological cycles | |
| biorhythm | ||
| RT | ES4.4.2 ovarian hormone secretion qh ah | |
| +ES12e menstrual cycle qh ah |
| EA8.18.2e | . . circadian rhythm qh |
| RT | +FF2.6.4e sleep qh ah |
| EA10e | biological structure qh |
| RT | +EJ16e skeletal function qh ah | |
| +GK disorder by body system or organ function qh ah | ||
| +HD general diagnostic method qh ah | ||
| +Xe body part qh ah | ||
| +XB4.2e connective tissue qh ah | ||
| +XG4e skeletal system qh ah | ||
| +XH skin system qh ah |
| EA10.2 | . body physical characteristic qh |
| SN | Include here general appearance, hirsuteness, skin color, and physical build. | |
| ST | somatotype | |
| RT | +GL4 musculoskeletal deformity qh ah |
| EA10.4e | . body composition qh |
| ST | body density | |
| RT | EA6 body chemistry qh ah |
| EA10.4.6e | . . total body water qh |
| HN | Introduced 2000. |
| EA10.6e | . body height qh |
| HN | ETOH descriptor 2000. | |
| BT | +HD2.4 body measurement qh ah |
| EA10.8e | . body weight qh |
| ST | body mass | |
| BT | +CB10 weight qh ah | |
| +HD2.4 body measurement qh ah | ||
| RT | EA24.6 nutritional state qh ah | |
| GF2.4.2e obesity qh ah | ||
| +GZ2.22.6 eating problem qh ah |
| EA10.8.2e | . . birth weight qh |
| NT | GJ2.12e low birth weight qh ah | |
| RT | +TA12.2.2e neonate qh ah |
| EA10.8.4e | . . body mass index qh |
| HN | Introduced 2000. | |
| ST | BMI |
| EA10.10e | . body part weight qh |
| HN | Introduced 2000. | |
| SN | Combine with the appropriate *+X body part* qh ah, e.g., for liver weight combine *+XM6 liver* qh ah with *+EA10.10 body part weight* qh ah. | |
| ST | body part mass | |
| body party density | ||
| organ weight |
| EA10.10.2e | . . bone mass density qh |
| HN | Introduced 2000. | |
| BT | +XB4.2.16e bone qh ah |
| EA10.10.4e | . . bone mineral density qh |
| HN | Introduced 2000. | |
| BT | +XB4.2.16e bone qh ah |
| EA12e | body temperature qh |
| HN | ETOH descriptor 1995. | |
| RT | +EA8.16e thermoregulation qh ah | |
| GF2.16 fever qh ah | ||
| GF2.18 chill qh ah | ||
| GH8.6.2e hyperthermia qh ah | ||
| GH8.6.4e hypothermia qh ah | ||
| +HD2 physical examination qh ah |
| EA14 | biological movement qh |
| RT | EG2.8.2e chemotaxis qh ah | |
| +EJe musculoskeletal function qh ah | ||
| +EJ10e muscle function qh ah | ||
| +GLe musculoskeletal and connective tissue disorder qh ah | ||
| +GL2.2e abnormal involuntary movement qh ah | ||
| +GL2.4.4.2e ataxia qh ah | ||
| GL2.4.4.2.2 gait abnormality qh ah |
| EA14.2 | . internal biological movement qh |
| RT | +EL2e blood circulation qh ah | |
| EP2.2 peristalsis qh ah | ||
| EP2.4e stomach emptying qh ah |
| EA14.2.2 | . . contraction or constriction qh |
| EA14.2.2.2 | . . . biological contraction qh |
| NT | EJ10.2e muscle contraction qh ah |
| EA14.2.2.4 | . . . biological constriction qh |
| ST | closing (biology) | |
| closure (biology) |
| EA14.2.4 | . . biological dilation qh |
| ST | aperture (biology) | |
| opening (biology) |
| EA14.4 | . external biological movement qh |
| HN | Introduced 2000. | |
| NT | +EJ8e locomotion qh ah |
| EA16 | biological relaxation qh |
| NT | EJ10.4e muscle relaxation qh ah | |
| RT | +EA22.4 biological rest qh ah | |
| GA2.2.2.4 inactive state qh ah |
| EA18e | stress qh |
| HN | ETOH descriptor 2000. | |
| SN | The general response of the body to any demand made on it. Use this broad term if both physiological and psychological aspects of stress are discussed, otherwise use a narrower term. | |
| NT | +FQe psychological stress qh ah | |
| RT | +FM adjustment qh ah | |
| +FNe motivation qh ah | ||
| +GA2e state of health qh ah | ||
| GH6.4 emotional trauma qh ah | ||
| +GZ32.2 acute stress reaction qh ah | ||
| +GZ32.4e adjustment reaction qh ah | ||
| LH2e quality of life qh ah | ||
| +LKe life event qh ah |
| EA18.2e | . stressor qh |
| HN | Introduced 2000. | |
| RT | +FQ6e psychosocial cause of stress qh ah | |
| +JA6.6e risk factors qh ah |
| EA18.2.2 | . . acute stressor qh |
| HN | Introduced 2000. | |
| SN | Temporary but significant life changes, major life events (e.g., death of a spouse, natural disasters, or loss of one's job). |
| EA18.2.4 | . . chronic stressor qh |
| HN | Introduced 2000. | |
| SN | Enduring sources of irritation and distress that might be related to work (e.g., trouble with coworkers), family (e.g., concern about a child's ongoing academic troubles), or other living pursuits (e.g., living in a high-crime neighborhood). |
| EA18.2.6 | . . traumatic stressor qh |
| HN | Introduced 2000. | |
| SN | Traumatic events such as childhood victimization, prisoner of war experiences, or serious physical injuries. | |
| RT | +GH6e trauma qh ah |
| EA18.4e | . physiological stress qh |
| ST | biochemical stress | |
| organic stress | ||
| RT | +GH8e disorder of environmental origin qh ah |
| EA18.4.2e | . . biological adaptation to stress qh |
| HN | ETOH descriptor 2000. | |
| NT | AJ6.24e tension reduction theory of AODU qh ah | |
| RT | +EU2.4e hypothalamic-pituitary-adrenal axis qh ah | |
| +FQ6.8.4 internal conflict qh ah |
| EA18.4.2.2e | . . . general adaptation syndrome qh |
| HN | ETOH descriptor 2000. | |
| ST | stress response | |
| BT | +GFe symptom qh ah | |
| RT | +FM4.10e defense mechanism qh ah |
| EA20 | stress moderator qh |
| HN | Introduced 2000. | |
| RT | +JA6.8e protective factors qh ah |
| EA22 | defense of body integrity qh |
| RT | +EKe skin function qh ah | |
| +ET4e immune function qh ah | ||
| +GG6 disruption of structural integrity qh ah | ||
| +XT6e reticuloendothelial system qh ah |
| EA22.2e | . biological adaptation qh |
| ST | biological/behavioral adaptation to environment | |
| RT | AE4.4 biological AOD tolerance qh ah | |
| +EE14.4 drug effect qh ah | ||
| EV4.4.4 ocular adaptation qh ah | ||
| +FM adjustment qh ah | ||
| GA12.6 adaptation to disease qh ah | ||
| +YG4 adaptive hormones qh ah |
| EA22.2.2e | . . body part rejection qh |
| HN | Introduced 2000. | |
| SN | Combine with the appropriate *+X body part* qh ah. | |
| ST | organ rejection |
| EA22.4 | . biological rest qh |
| ST | dormancy | |
| hibernation | ||
| RT | +EA8.4e biological activation qh ah | |
| +EA16 biological relaxation qh ah | ||
| +FF2.6.4e sleep qh ah | ||
| GA2.2.2.4 inactive state qh ah |
| EA22.4.2e | . . fatigue qh |
| HN | ETOH descriptor 2000. | |
| ST | tiredness | |
| RT | +GF2 physical symptom qh ah | |
| +OR12e accident factor qh ah |
| EA22.4.2.2 | . . . physical exhaustion qh |
| ST | physical extenuation |
| EA22.4.2.4 | . . . psychogenic fatigue qh |
| ST | asthenia | |
| decreased energy | ||
| lethargy | ||
| malaise | ||
| RT | +OR12e accident factor qh ah |
| EA22.6e | . biological repair qh |
| ST | biological healing | |
| RT | +EDe growth and development qh ah | |
| GA12.8.8 disease reversibility qh ah | ||
| GA12.8.12e recovery from disease qh ah | ||
| GG18 abnormal tissue repair qh ah |
| EA22.6.2 | . . restoration of structure qh |
| RT | EA8.14 biological integration qh ah |
| EA22.6.2.2 | . . . granulation tissue qh |
| BT | +XB4e tissue qh ah |
| EA22.6.2.4 | . . . cicatrization qh |
| EA22.6.2.6e | . . . regeneration of body part qh |
| HN | ETOH descriptor 1995. | |
| SN | Combine with the appropriate *+X body part* qh ah, for example, for liver regeneration, combine *EA22.6.2.6 regeneration of body part* qh ah with *+XM6 liver* qh ah. | |
| ST | body part regeneration | |
| organ regeneration |
| EA22.6.4 | . . biological function restoration qh |
| EA22.8 | . biological remodeling qh |
| EA24e | nutrition qh |
| SN | Nutrient intake and absorption. | |
| RT | +EBe metabolism qh ah | |
| EL2.8 blood inflow qh ah | ||
| +EPe digestion qh ah | ||
| +GZ2.22.6 eating problem qh ah | ||
| +GZ24e eating disorder qh ah | ||
| +HS2 nutritional therapy qh ah | ||
| +JH4e health related behavior qh ah | ||
| +YAe nutrients qh ah |
| EA24.2e | . diet qh |
| RT | +GH14e nutritional disorder qh ah | |
| HD8 dietary assessment qh ah |
| EA24.4e | . nutritional value or requirement qh |
| RT | +YAe nutrients qh ah | |
| +YA4e mineral nutrients qh ah |
| EA24.4.2 | . . caloric value or requirement qh |
| EA24.4.2.2e | . . . caloric value qh |
| HN | Introduced 1995. |
| EA24.4.2.4 | . . . caloric requirement qh |
| HN | Introduced 1995. |
| EA24.6 | . nutritional state qh |
| RT | +EA10.8e body weight qh ah | |
| +GH14e nutritional disorder qh ah |
| EA24.8e | . nutrient intake qh |
| ST | drinking | |
| eating | ||
| feeding | ||
| food intake | ||
| nutrient ingestion | ||
| RT | EF4.2.2 oral enteral administration qh ah | |
| +ENe oral function qh ah | ||
| +EPe digestion qh ah | ||
| EP2.10 gastrointestinal digestion qh ah | ||
| +OG food product qh ah |
| EA24.8.2 | . . eating behavior qh |
| ST | ingestive behavior | |
| RT | +GZ2.22.6 eating problem qh ah | |
| +GZ24e eating disorder qh ah |
| EA24.8.4e | . . breast feeding qh |
| HN | ETOH descriptor 2000. | |
| RT | ES24e lactation qh ah | |
| +LG14.4.4 child-rearing practice qh ah |
| EA24.8.6e | . . energy intake qh |
| HN | Introduced 2000. |
| EA24.8.8 | . . nutrient intake regulation qh |
| BT | +EA8e biological regulation qh ah |
| EA24.8.8.2e | . . . hunger qh |
| HN | ETOH descriptor 2000. | |
| BT | +FN6 needs and drives qh ah |
| EA24.8.8.4e | . . . thirst qh |
| HN | ETOH descriptor 2000. | |
| BT | +FN6 needs and drives qh ah |
| EA24.8.8.6e | . . . appetite qh |
| HN | ETOH descriptor 2000. | |
| RT | AE6e AOD craving qh ah | |
| +GZ2.22.6 eating problem qh ah |
| EA24.8.8.8 | . . . satiation qh |
| EA24.8.8.10 | . . . fasting qh |
| EA24.10e | . nutrient absorption qh |
| ST | food absorption (stomach) | |
| RT | EP2.12e gastrointestinal absorption qh ah |
| EA26e | respiration qh |
| ST | oxygenation | |
| RT | +ELe cardiovascular system function qh ah | |
| +EMe respiratory system function qh ah | ||
| +ET2e blood function qh ah | ||
| +GOe respiratory disorder qh ah | ||
| HQ2.4 artificial respiration qh ah | ||
| XS2.6e erythrocytes qh ah |
| EBe | metabolism d-out qh |
| HN | Changed descriptor 1995; through 1995 also use "substrate metabolism." | |
| SN | The processes by which the body uses enzymes and other biochemicals to break down ingested substances, such as foods and drugs, so that they may be consumed and eliminated (catabolism) as well as the
processes by which the body synthesizes substances (anabolism). If specific chemical reactions are discussed, use an appropriate term from *+CL chemical reaction* qh ah.
Use *+EB10 drug metabolism* qh ah to index documents about the metabolism of *+B AOD substance or product* qh ah (with the exception of alcohol) or *+YN therapeutic agents* qh ah as well as *+YX toxic substances* qh ah and *+YZ miscellaneous substances* qh ah. | |
| BT | +EAe general life processes qh ah | |
| +EA4e biochemical mechanism qh ah | ||
| RT | +EA24e nutrition qh ah | |
| +EEe pharmacology and toxicology qh ah | ||
| +EE14.4 drug effect qh ah | ||
| +EE16e drug interaction qh ah | ||
| +GRe metabolic disorder qh ah | ||
| HG18.2.4 basal metabolism qh ah | ||
| +Xe body part qh ah |
| EB2e | . homeostasis qh |
| SN | A state of equilibrium within an individual that is brought about by internal regulatory processes. These processes are automatic, are largely chemical in nature, and affect physiological and psychological systems. | |
| SN | The body's capacity to maintain normal, internal stability by coordinated responses of organ systems that automatically compensate for environmental changes. | |
| ST | metabolic equilibrium | |
| RT | +EA8e biological regulation qh ah | |
| +ER2e kidney function qh ah | ||
| +EW12.6.4.6 diencephalic brain model qh ah | ||
| +GR20e disorder of fluid or electrolyte or acid-base balance qh ah | ||
| HR14 fluid therapy qh ah |
| EB2.2 | . . electrolyte balance qh |
| HN | Introduced 2000. |
| EB4e | . bioenergetics qh |
| SN | The study of energy changes in living organisms. | |
| RT | +CJ2e thermodynamics qh ah | |
| EB6e biodegradation qh ah | ||
| +EB8e biosynthesis qh ah |
| EB4.2 | . . high-energy compound qh |
| ST | energy-rich bonds | |
| NT | +YD4.2.2 acyl CoA qh ah | |
| YD4.2.2.2 acetyl CoA qh ah | ||
| ZC14.2.2.2.2e pyrophosphate qh ah | ||
| ZJ2.10.4.10e phosphoenolpyruvate qh ah | ||
| ZO2.12.4e S-adenosylmethionine qh ah | ||
| ZO2.14.2e creatine phosphate qh ah | ||
| ZS8.4e uridine diphosphate glucose qh ah | ||
| +ZS8.22e NADP qh ah | ||
| +ZS8.44 nucleoside triphosphate qh ah |
| EB4.4e | . . electron transfer qh |
| ST | electron transport | |
| BT | +CM2e oxidation-reduction qh ah | |
| +EG16.2e mitochondrial transport qh ah |
| EB4.4.2 | . . . microsomal electron transfer qh |
| RT | +YD6.6e cytochrome P450 qh ah |
| EB4.6 | . . tricarboxylic acid cycle qh |
| ST | Krebs cycle | |
| RT | ZJ2.12.4e tricarboxylic acid qh ah |
| EB4.8e | . . oxidative phosphorylation qh |
| HN | ETOH descriptor 2000. | |
| ST | ATP cycle | |
| BT | +CM34e phosphorylation qh ah |
| EB6e | . biodegradation qh |
| ST | biotransformation | |
| catabolism | ||
| metabolic breakdown | ||
| BT | +CL6e chemical breakdown qh ah | |
| RT | +EB4e bioenergetics qh ah |
| EB8e | . biosynthesis qh |
| SN | In general, combine *+EB8 biosynthesis* qh ah with the specific compound in *+Y chemical substances by function* qh ah or *+Z chemical substances by structure* qh ah for the synthesis of a particular substance. | |
| ST | anabolism | |
| BT | +CL8e chemical synthesis qh ah | |
| RT | +EB4e bioenergetics qh ah |
| EB8.2e | . . protein synthesis qh |
| RT | EB18e protein metabolism qh ah |
| EB10e | . drug metabolism qh |
| SN | Use *+EB10 drug metabolism* qh ah to index documents about the metabolism of *+B AOD substance or product* qh ah, *+YN therapeutic agents* qh ah, *+YX toxic substances* qh ah, and *+YZ miscellaneous substances* qh ah. | |
| ST | drug biotransformation | |
| NT | +EE12.6.12.2.6.4 hepatic drug clearance qh ah | |
| BT | +EE12e pharmacokinetics qh ah | |
| +EE12.6.12e drug clearance qh ah | ||
| RT | +Be AOD substance or product qh ah | |
| +EBe metabolism qh ah | ||
| +EE14.4 drug effect qh ah | ||
| +EP6e liver function qh ah | ||
| +GB AODD and AODR disorder qh ah | ||
| +XM6e liver qh ah | ||
| +YXe toxic substances qh ah | ||
| +YZ miscellaneous substances qh ah | ||
| +YZ18e volatile substances qh ah |
| EB10.2 | . . phase I drug biotransformation qh |
| RT | +CM2e oxidation-reduction qh ah | |
| CM14 dealkylation qh ah | ||
| CM26e hydroxylation qh ah | ||
| YC14.22.4 mixed function oxidase qh ah | ||
| +YD6.6e cytochrome P450 qh ah |
| EB10.4 | . . phase II biotransformation qh |
| ST | biosynthetic biotransformation | |
| drug conjugation | ||
| RT | CM10.2 acetylation qh ah | |
| CM28 sulfation qh ah |
| EB10.6 | . . microsomal drug biotransformation qh |
| RT | +CM2e oxidation-reduction qh ah | |
| XA2.4.4e microsome qh ah | ||
| +YD6.6e cytochrome P450 qh ah |
| EB10.8e | . . drug detoxification qh |
| SN | The metabolism and, presumably, the progressive reduction (or biodegradation) of drugs and drug metabolites having toxic effects. Do not confuse with therapeutic *+JQ6.4.2.4 detoxification* qh ah, as in detoxification of substance abusers. | |
| RT | +EP6e liver function qh ah | |
| +JQ6.4.2.4e detoxification qh ah | ||
| +XM6e liver qh ah |
| EB10.10e | . . drug excretion qh |
| HN | ETOH descriptor 2000. | |
| ST | drug elimination | |
| NT | EE12.6.12.2.6.2 renal drug clearance qh ah | |
| BT | +EC2.14e excretion qh ah | |
| +EE12.6.12e drug clearance qh ah | ||
| RT | XH6.8 nail qh ah | |
| XH6.10 hair qh ah |
| EB10.12e | . . ethanol metabolism qh |
| ST | alcohol metabolism | |
| ethanol breakdown | ||
| ethanol catabolism | ||
| BT | +BB2e ethanol qh ah | |
| RT | +BX2.2.4e congener qh ah | |
| +EA8e biological regulation qh ah | ||
| +GR2e ethanol metabolism disorder qh ah | ||
| +YC14.2.2e alcohol dehydrogenases qh ah | ||
| ZT6.2e cocaethylene qh ah |
| EB10.12.2e | . . . major ethanol pathway qh |
| HN | ETOH descriptor 2000. |
| EB10.12.2.2e | . . . . ethanol-to-acetaldehyde metabolism qh |
| EB10.12.2.4e | . . . . acetaldehyde-to-acetate metabolism qh |
| RT | +YC14.4e aldehyde oxidoreductases qh ah | |
| +YC14.4.2e aldehyde dehydrogenases qh ah | ||
| YC14.12.6e xanthine oxidase qh ah |
| EB10.12.2.6e | . . . . acetate catabolism qh |
| EB10.12.4e | . . . minor ethanol pathway qh |
| HN | ETOH descriptor 2000. | |
| RT | YD6.6.4e MEOS qh ah |
| EB10.12.4.2 | . . . . nonenzymic ethanol oxidation qh |
| EB10.12.4.4 | . . . . catalase dependent ethanol oxidation qh |
| EB10.12.4.6 | . . . . nonoxidative ethanol catabolism qh |
| EB10.12.6e | . . . endogenous ethanol production qh |
| ST | ethanol anabolism |
| EB10.12.6.2 | . . . . gut fermentation qh |
| EB10.12.8e | . . . ethanol metabolite qh |
| RT | +ZG2e aldehydes qh ah | |
| +ZG2.4e acetaldehyde qh ah | ||
| +ZJ2.6.4.2e acetate qh ah |
| EB12e | . carbohydrate metabolism qh |
| BT | +ZHe carbohydrates qh ah | |
| RT | +GR4e carbohydrate metabolism disorder qh ah |
| EB12.2e | . . glucose metabolism qh |
| BT | +ZH2.12.2e glucose qh ah |
| EB12.2.2e | . . . gluconeogenesis qh |
| HN | ETOH descriptor 1995. |
| EB12.2.4 | . . . glycogenesis qh |
| RT | +XM6e liver qh ah |
| EB12.2.6 | . . . glycogenolysis qh |
| EB12.2.8e | . . . glycolysis qh |
| HN | ETOH descriptor 1995. |
| EB12.4 | . . pentose phosphate shunt qh |
| EB14e | . lipid metabolism qh |
| BT | +ZK lipids, fatty acids, fats and oils qh ah | |
| RT | EB22e hormone metabolism qh ah | |
| +GR6e lipid metabolism disorder qh ah | ||
| +ZVe steroids qh ah |
| EB16e | . amino acid metabolism qh |
| BT | +ZO2e amino acids qh ah | |
| RT | GR8e amino acid metabolism disorder qh ah |
| EB16.2 | . . urea cycle qh |
| RT | ZM6e urea qh ah |
| EB18e | . protein metabolism qh |
| BT | +ZO6e proteins qh ah | |
| RT | EB8.2e protein synthesis qh ah | |
| +GR10e protein metabolism disorder qh ah |
| EB20e | . nucleic acid metabolism qh |
| BT | +ZS4e nucleic acids qh ah | |
| RT | +EX8e molecular genetics qh ah |
| EB20.2e | . . DNA metabolism qh |
| ST | deoxyribonucleic acid metabolism | |
| BT | +ZS4.6e DNA qh ah | |
| RT | EX8.2 DNA genetics qh ah |
| EB20.2.2e | . . . DNA replication qh |
| HN | ETOH descriptor 2000. | |
| ST | deoxyribonucleic acid synthesis | |
| DNA synthesis | ||
| RT | +EX8e molecular genetics qh ah | |
| YC16.14.2.2.2e DNA polymerase qh ah |
| EB20.2.4 | . . . DNA repair qh |
| ST | deoxyribonucleic acid repair | |
| RT | +EX8e molecular genetics qh ah | |
| +EX10.2e mutagenesis qh ah | ||
| YC16.14.2.2.2e DNA polymerase qh ah |
| EB20.4e | . . RNA metabolism qh |
| ST | ribonucleic acid metabolism | |
| BT | +ZS4.8e RNA qh ah | |
| RT | EX8.6.6e RNA translation qh ah |
| EB22e | . hormone metabolism qh |
| BT | +YFe hormones qh ah | |
| RT | EB14e lipid metabolism qh ah | |
| +EUe endocrine function qh ah | ||
| +GVe endocrine disorder qh ah | ||
| +XUe endocrine system qh ah | ||
| +ZO4e peptides qh ah | ||
| +ZVe steroids qh ah |
| EB24e | . neurotransmitter metabolism qh |
| BT | +YJ2e neurotransmitters qh ah | |
| RT | +EW6e neurotransmission qh ah |
| EB26e | . bile acid metabolism qh |
| BT | +YT10.10e bile acids and salts qh ah | |
| RT | +EP6e liver function qh ah | |
| +GQ12.4e cholelithiasis qh ah | ||
| XM6.6e bile qh ah |
| EB28e | . mineral metabolism qh |
| BT | +YA4e mineral nutrients qh ah | |
| RT | +GH14.4.8e mineral deficiency qh ah | |
| +GR12e mineral metabolism disorder qh ah |
| EB28.2e | . . calcium metabolism qh |
| BT | +ZA2.4.4.6e calcium qh ah | |
| RT | +EW6e neurotransmission qh ah | |
| GL14.8e osteoporosis qh ah | ||
| GL14.10 osteomalacia qh ah |
| EB28.2.2 | . . . calcification qh |
| RT | EJ16.2e bone ossification qh ah | |
| +GR12.10e calcium metabolism disorder qh ah |
| EB28.2.4 | . . . decalcification qh |
| RT | EJ16.4e bone resorption qh ah | |
| +GR12.10e calcium metabolism disorder qh ah |
| EB28.4e | . . phosphorus metabolism qh |
| BT | +ZA2.12.4e phosphorus qh ah | |
| +ZC14e inorganic phosphorus compounds qh ah | ||
| RT | GR12.8 phosphorus metabolism disorder qh ah |
| EB28.6e | . . iron metabolism qh |
| BT | +ZA2.20.2.10e iron qh ah | |
| RT | +GR12.2e iron metabolism disorder qh ah | |
| +GT2.6e anemia qh ah | ||
| +ZO6.4.10.2e hemoglobin qh ah | ||
| +ZO6.4.10.8.4.2e transferrin qh ah |
| EC | biological transport and storage d-out qh |
| BT | +EAe general life processes qh ah |
| EC2e | . biological transport qh |
| SN | Use for molecular process of transport across cell membranes, for movement of certain substrates through the body (e.g., oxygen and carbon dioxide), and for macrotransport, as in the digestive system. For documents about membrane structure or the structure of specific channels (e.g., calcium channel), use *+EG14.8 membrane channel* qh ah or one of its narrower terms. | |
| NT | +EE12.4.2 drug transfer across body barrier qh ah | |
| +EG16.2e mitochondrial transport qh ah | ||
| +ET2.2e blood transport function qh ah | ||
| RT | +EG14 cell membrane biology qh ah | |
| +EG14.8e membrane channel qh ah |
| EC2.2e | . . active transport qh |
| SN | Any ATP-driven cellular process for moving solutes or organelles (e.g., ATPase transmembrane pumps, pinocytosis and related membrane flux events, and cytoskeletal rearrangements). | |
| RT | ZO6.4.6.4e membrane transport protein qh ah |
| EC2.4e | . . carrier mediated transport qh |
| EC2.6e | . . passive transport qh |
| RT | EG14.6e membrane permeability qh ah | |
| EG14.8.2 nongated membrane channel qh ah | ||
| +EM8 pulmonary gas exchange qh ah |
| EC2.6.2 | . . . carbon dioxide transport qh |
| RT | +EM8 pulmonary gas exchange qh ah | |
| ET2.2.2 blood gas transport qh ah |
| EC2.6.4 | . . . oxygen transport qh |
| RT | +EM8 pulmonary gas exchange qh ah | |
| ET2.2.2 blood gas transport qh ah |
| EC2.8e | . . intracellular transport qh |
| ST | axoplasmic flow | |
| cytoplasmic streaming |
| EC2.10e | . . ion transport qh |
| RT | +EG14.8e membrane channel qh ah | |
| YD8.12.2e ionophores qh ah |
| EC2.12e | . . secretion qh |
| ST | secretion process | |
| NT | EP2.6 gastric secretion qh ah | |
| EP2.8e intestinal secretion qh ah | ||
| ES4.4.2 ovarian hormone secretion qh ah | ||
| ES4.6.4 testicular hormone secretion qh ah | ||
| +EV4.6 lacrimation qh ah | ||
| +GG12.2 abnormal secretion qh ah | ||
| RT | EN4 salivation qh ah | |
| ER2.4.4 renal tubular secretion qh ah | ||
| ES4.6.2 semination qh ah | ||
| +XB2.8e secretion product qh ah |
| EC2.14e | . . excretion qh |
| ST | excretion process | |
| exocrine secretion | ||
| external secretion | ||
| NT | +EB10.10e drug excretion qh ah | |
| RT | +ER2e kidney function qh ah | |
| +XB2.10e excretion product qh ah |
| EC2.16e | . . biological waste elimination qh |
| NT | EM2.6 exhalation qh ah | |
| EP2.16.2 bowel movement qh ah | ||
| ER4.2e urination qh ah | ||
| RT | +EK2e sweating qh ah | |
| +ELe cardiovascular system function qh ah | ||
| EL2.10 blood outflow qh ah | ||
| +EPe digestion qh ah | ||
| +ER2.4 renal tubular function qh ah | ||
| +ER4e bladder function qh ah | ||
| XT6.4e macrophage qh ah |
| EC4 | . biological storage qh |
| SN | Physiological storage of nutrients for later use (e.g., glycogen stores, adipose tissue). | |
| RT | +XB4.2.10e adipose tissue qh ah |
| EC6 | . biological reservoir qh |
| SN | Accumulation of products in a hollow viscus for secretion or excretion. | |
| RT | +EP2.16 rectal function qh ah | |
| +ER4e bladder function qh ah | ||
| +XM2.4.10e rectum qh ah | ||
| +XM8e gallbladder qh ah | ||
| XP6e bladder qh ah |
classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept